Aleksandar M. Veselinovic
Orcid: 0000-0001-9291-6654
According to our database1,
Aleksandar M. Veselinovic authored at least 8 papers
between 2015 and 2026.
Collaborative distances:
Collaborative distances:
Timeline
Legend:
Book In proceedings Article PhD thesis Dataset OtherLinks
On csauthors.net:
Bibliography
2026
Design and evaluation of dual c-Met/β-tubulin inhibitors for triple-negative breast cancer: An In Silico approach.
Comput. Biol. Chem., 2026
2024
In silico development of novel angiotensin-converting-enzyme-I inhibitors by Monte Carlo optimization based QSAR modeling, molecular docking studies and ADMET predictions.
Comput. Biol. Chem., 2024
2021
In silico development of potential therapeutic for the pain treatment by inhibiting voltage-gated sodium channel 1.7.
Comput. Biol. Medicine, 2021
2020
In silico development of anesthetics based on barbiturate and thiobarbiturate inhibition of GABA<sub>A</sub>.
Comput. Biol. Chem., 2020
2019
Development and design of novel cardiovascular therapeutics based on Rho kinase inhibition - In silico approach.
Comput. Biol. Chem., 2019
2018
The anesthetic action of some polyhalogenated ethers - Monte Carlo method based QSAR study.
Comput. Biol. Chem., 2018
2015
Monte Carlo method based QSAR modeling of maleimide derivatives as glycogen synthase kinase-3β inhibitors.
Comput. Biol. Medicine, 2015
QSAR modeling of the antimicrobial activity of peptides as a mathematical function of a sequence of amino acids.
Comput. Biol. Chem., 2015